Press release
Biomanufacturing Viral Detection and Quantification Market Deep Research Report with Forecast to 2031
According to the latest research by InsightAce Analytic, the global Biomanufacturing Viral Detection and Quantification Market size is valued at US$ 466.52 Million in 2022, and it is expected to reach US$ 981.41 Million in 2031, recording a promising CAGR of 8.8% during the forecast period of 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1918
Viral detection and quantification are critical components in biomanufacturing processes, especially when viruses serve as active pharmaceutical ingredients. These procedures involve the precise analysis and measurement of viral loads within the large-scale production of biological products, including vaccines, therapeutic proteins, and viral vectors. Accurate viral monitoring ensures product consistency, quality, and safety throughout the manufacturing lifecycle. The selection of detection and quantification methods is tailored to meet the specific requirements of each biomanufacturing process.
Biological therapies are inherently susceptible to contamination by bacteria, fungi, and viruses, which poses significant risks to production timelines and ultimately impacts healthcare delivery. Early identification of such contaminants is essential to mitigate production delays and maintain operational efficiency.
Some of the prominent players in the Biomanufacturing Viral Detection and Quantification Market are:
• Danaher Corporation
• Merck KGaA
• New England Biolabs
• TAKARA HOLDINGS INC.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Sartorius AG
• Charles River Laboratories
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN N.V.
• Genscript Biotech Corporation
• Norgen Biotek Corp.
• Other Prominent Players
Market Dynamics:
Drivers:
The biomanufacturing viral detection and quantification market is propelled by several key factors, including the rapid advancement of technologies aimed at improving the detection and measurement of viral contaminants, the expanding adoption of biopharmaceuticals, the growing emphasis on stringent quality control (QC) protocols, and continuous innovations in viral testing methodologies.
Increasing usage of biopharmaceuticals:
The quality of biopharmaceutical products is ensured through viral detection and quantification, which is essential to biopharmaceutical industries. QC (Quality Control) measures are necessary to maintain the safety, efficacy and consistency of biopharmaceuticals. Thus, the demand for viral testing technologies is increasing, surging the growth opportunities for the biomanufacturing viral detection and quantification market.
Advancements in viral testing technologies:
The development of assays such as polymerase chain reaction (PCR) and real-time PCR (qPCR) allows rapid and accurate virus detection by measuring the nucleic acid of the virus with certain accuracy and sensitivity.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1918
Challenges:
Market growth may be constrained by the high capital investment required for advanced viral detection instrumentation and the shortage of skilled personnel capable of operating and interpreting complex testing systems.
Regional Trends:
North America is anticipated to maintain a dominant market share throughout the forecast period, driven by robust demand for biological therapies, progressive advancements in contaminant detection technologies, and substantial government funding aimed at optimizing biomanufacturing processes. Concurrently, the Asia Pacific region is expected to experience the fastest growth rate, supported by an increasing number of biopharmaceutical companies, well-developed industrial infrastructure, government initiatives to enhance product quality, ongoing innovation in cell and gene therapies, and the expanding capabilities of contract manufacturing organizations within the region.
Key Developments In The Market:
• In September 2019, Merck KGaA partnered with Pfizer Inc. and launched a new drug BAVENCIO for t[the removal of viruses.
• In July 2018, Diversigen Inc. and Norgen Biotek Corp. entered into a strategic partnership through which industry and academic researchers will benefit from comprehensive end-to-end logistical, sequencing, and analytical solutions to meet the growing needs for microbiome analyses.
• In July 2016, Sartorius acquired ViroCyt for $16 million to expand the buyer's lab products and services offerings by adding the developer of rapid virus quantification tools. The deal is Sartorius' second tools acquisition in less than 3 weeks. On June 28, Sartorius signaled its expansion into bioanalytics by purchasing cell screening platforms developer IntelliCyt for $90 million.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/1918
Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Offering Type
• Consumables
• Instruments
• Services
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Technology
• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Application
• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End User
• Life Science Companies
• Testing Laboratories
• CROs and CDMOs
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• U.S.
• Canada
Europe Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Get More Information :
https://www.insightaceanalytic.com/report/biomanufacturing-viral-detection-and-quantification-market/1918
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomanufacturing Viral Detection and Quantification Market Deep Research Report with Forecast to 2031 here
News-ID: 4023614 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Cell and Gene Therapy Manufacturing Quality Control (QC) Market Current Scenario …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market - (By Component (Equipment & Accessories, Consumables, Others), By Application (Sterility Testing, Purity Testing, Potency Testing, Identity Testing, Others (stability, viability, etc.)), By Process (Upstream Processing, Downstream Processing, Packaging), By End-User (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Celecoxib API Market Deep Research Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celecoxib API Market- (By Type (Standard Grade Celecoxib API, & Micronized Celecoxib API), By Application (Pharmaceutical, & Laboratory)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Celecoxib API Market Size was valued at USD 58.9 Mn in 2023 and is predicted to reach USD 87.0…
cDNA Clone Vectors Market Growth and Restrain Factors Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global cDNA Clone Vectors Market - (By Type (Rat, Cat, Dog, Monkey, Human, Others), By Application (BioScience Companies, Hospital and Clinics, University and Institutions, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global cDNA Clone Vectors Market Size is valued at USD 120.8 Mn in 2023…
Catastrophic Antiphospholipid Syndrome Market expected to Witness Huge Revenue G …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Catastrophic Antiphospholipid Syndrome Market- (By Treatment (Anticoagulants, Immunosuppressive Therapy, Plasma Exchange Therapy, Intravenous Immunoglobulin (IVIG) and Others), By End-use (Hospitals, Clinics, Others), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Catastrophic Antiphospholipid Syndrome Market Size was valued at USD 4.38 Bn in 2023…
More Releases for Viral
Viral Inactivation Market Growing Demand of Kits and Reagents Viral Inactivation …
According to Precision Business Insights (PBI), the latest report, the Viral Inactivation market is expected to be worth USD 2.1 billion in 2022, growing at a 12.8% CAGR from 2022 to 2028. The primary driver of the expansion of the global Viral Inactivation market are speedy growth in pharmaceutical and biotechnology industries and strong inclination of R&D investments in life sciences industry.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/viral-inactivation-market/
Kits &…
Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry …
Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin.
According to study, “Anti-Viral Drug Therapy…
Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, …
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,…
Viral Vector and Plasmid DNA Manufacturing Market - Increase In Awareness Regard …
The Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the viral vector and plasmid DNA markets in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period.
Gene therapy has included tools such as viral vectors…
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent…
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in…
